6 APPLIEDSCIENCES

THAT WILLTRANSFORM

CANCERRESEARCH

Gil Schwartzberg

Many companies are revolutionizing

diagnostics by improving liquid

biopsies that can seek out cancer cells

or tumor DNA that are shed by tumors

in the blood.

LIQUID BIOPSYFOR ONCOLOGY :

Our human microbiome is may prove

significant in the evolution of cancer

immunotherapies that utilize gut

microbes.

THE MICROBIOME

Patient-specific testings are aiding

researchers with anticipating proper

individual treatment reverberstion to

therapies.

PATIENT -SPECIFICRESEARCH

Single-cell molecular profiling may

significantly impact the resolution of

intratumor heterogeneity, understand

rare tumor cell populations, measure

mutation rates, and trace cell lineage.

SINGLE -CELLMOLECULARPROFILING

Researchers are now using

nanotechnology to carefully distribute

therapeutics to cancer cells and

strengthen the therapeutic potency of

specific treatments.

NANOTECHNOLOGY

Stakeholders will continue to improve

the value of cancer care by Revamping

payment structures, disposing of

inadequate therapies, and assisting

doctors as well as patients avert

improper treatment.

REEVALUATINGTHE VALUE INCANCERADVANCEMENTS